GO
Loading...

Lazard Ltd

More

  • *FTSE 100 has lost over 8 percent since Sept. 4. The decision to scrap the offering, which could have valued the firm at about 800 million pounds, casts a shadow over the prospects of the bigger and more widely known Virgin Money, another bank seeking to list this month. Aldermore and Virgin are among so-called challenger banks which the government hopes can break the...

  • LONDON, Oct 14- GlaxoSmithKline is seeking binding bids by next month for a range of older drugs worth more than $3 billion, which it is likely to sell by geographical region, according to people with direct knowledge of the process. Britain's biggest drug maker is looking to divest the mature products in a bid to improve its growth profile and wants to dispose of...

  • NEW YORK/ HOUSTON, Oct 9- Investment bank Lazard Ltd has asked bidders that have shown interest in buying Citgo Petroleum Corp's U.S. refineries to submit an additional round of offers, people close to the deal told Reuters this week as the sale process proceeds despite doubts. Venezuela's state-run oil company PDVSA hired Lazard to handle the sale process for...

  • NEW YORK, Sept 28- NiSource Inc on Sunday announced its board had approved plans to split into two publicly traded companies, separating its utilities and pipeline businesses. Under the plan, NiSource will list its natural gas pipeline division as Columbia Pipeline Group, which is expected to trade on the New York Stock Exchange under the ticker "COLP."

  • NEW YORK, Sept 28- NiSource Inc on Sunday announced its board had approved plans to split into two publicly traded companies, separating its utilities and pipeline businesses, with the new company taking the form of a master limited partnership.

  • FRANKFURT, Sept 22- Germany's Siemens AG has agreed to buy U.S. oilfield equipment maker Dresser-Rand Group Inc for $7.6 billion in cash, paying a relatively rich price to belatedly beef up its presence in the U.S. shale oil and gas industry.

  • HOUSTON, Sept 22- The fast-changing nature of crude oil flows in the Americas means only one of three Citgo refineries in the United States will generate keen interest among buyers as Venezuela's cash-strapped state-run PDVSA looks to sell its U.S. unit, and it may fetch less money than hoped, experts say.

  • NEW YORK, Sept 9- Venezuela's state-run oil company PDVSA is seeking preliminary offers for its U.S. unit Citgo Petroleum Corp by the end of September, a deal that could fetch up to $10 billion, according to two people familiar with the matter.

  • Alibaba IPO legal fees dwarf Facebook's Friday, 5 Sep 2014 | 8:09 PM ET

    Sept 5- Alibaba Group Holding Ltd disclosed on Friday that it would pay $15.8 million in legal fees to law firm Simpson Thacher and other attorneys who advised the Chinese e-commerce giant on its upcoming IPO, six times what Facebook paid its counsel two years ago.

  • PRESS DIGEST-Sunday British Business - AUG 31 Sunday, 31 Aug 2014 | 9:28 AM ET

    LONDON, Aug 31- British newspapers reported the following business stories on Sunday. GlaxoSmithKline is facing a shareholder revolt over plans to shake up its board, with leading investors calling for the speedy departure of Chairman Christopher Gent.

  • Aug 22- Power company Dynegy Inc said on Friday that it would buy coal and gas power plants for $6.25 billion to increase its presence in two less regulated eastern U.S. markets. Dynegy shares rose as much as 22.5 percent in early trading.

  • Aug 22- U.S. power company Dynegy Inc said on Friday that it would buy coal and gas generation assets from Duke Energy Corp and Energy Capital Partners, in two deals totaling $6.25 billion.

  • *Walgreen to buy remaining 55 pct of Alliance Boots. *Walgreen says inversion deal not in interests of investors. Aug 6- U.S. retailer Walgreen Co said it would not use a full takeover of Europe's biggest pharmacy chain, Alliance Boots, to move its domicile overseas, following fierce criticism of such tax-cutting deals at home.

  • *Walgreen to buy remaining 45 pct of Alliance Boots. *Walgreen says inversion deal not in interests of investors. Aug 6- U.S. retailer Walgreen Co won't use a full takeover of Europe's biggest pharmacy chain Alliance Boots to move its domicile overseas, it said on Wednesday, following fierce criticism of such tax-cutting deals at home.

  • NEW YORK, Aug 5- Belgian pharmaceutical company UCB is exploring a sale of its Kremers Urban Pharmaceuticals Inc division, a U.S. specialty generics business that could fetch as much as $2 billion, according to people familiar with the matter. Other companies that are exploring similar sales include GlaxoSmithKline Plc, Sanofi SA and Merck& Co Inc..

  • *Iliad bid $15 bln for 56.6 pct of T-Mobile US at $33/ share. PARIS/ FRANKFURT, Aug 1- Telecoms group Iliad has lined up BNP Paribas and HSBC to finance its bid for T-Mobile US, people familiar with the matter said, as it pursues a deal that could overturn expectations of industry consolidation in both the United States and France.

  • *Iliad lines up deal financing with BNP, HSBC- sources. *Iliad bid $15 bln for 56.6 percent of T-Mobile US at $33/ share. PARIS, Aug 1- French telecoms company Iliad has lined up financing for its $15 billion bid for 56.6 percent of T-Mobile US from BNP Paribas and HSBC, three people familiar with the matter said on Friday.

  • July 24- Investment bank and asset manager Lazard Ltd reported a better-than-expected quarterly profit, as merger and acquisition advisory and asset management fees rose amid an increase in corporate deals. In one of its big deals in the second quarter, Lazard advised jet engine parts maker Firth Rixson on the $2.85 billion sale to aluminum group Alcoa Inc..

  • Lazard profit jumps 43 pct on higher M&A advisory fees Thursday, 24 Jul 2014 | 7:06 AM ET

    The company's adjusted net profit rose to $85 million, or 64 cents per share, in the second quarter ended June 30 from $60 million, or 45 cents per share, a year earlier.

  • LONDON/ MUMBAI, July 22- Indian generics firm Lupin, some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being auctioned by GlaxoSmithKline, five sources familiar with the matter said.